Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Molecular Diagnostics, |
RCV002266553 | SCV002548543 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 3 | 2022-05-15 | criteria provided, single submitter | clinical testing | TP53:c.74+23C>T is present in 0.00040% in the large population studies (GnomAd). The variant is predicted to create a de novo donor splice site in intron 2 by in silico splicing tools. Functional RNA study has shown that the variant causes insignificant splicing aberration leading to an out-of-frame transcript (PMID: 35806449). Therefore the variant was classified as likely benign (ACMG/AMP: BS3-Stand alone) |